Joseph A. Tyndall is Director at Axogen, Inc. (AXGN). They have made 4 open-market trades across 1 company since 2025, most recently 2026-09-02.
CIK 0001955281
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AXGN | 10,650 | $547K |
Shares reported on the most recent Form 4, priced at the 2026-09-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AXGN | SELL · 10b5-1 | 2026-09-02 | 2026-09-04 | $49.70 | $174K | -4.1% | -21.1% | — |
| AXGN | SELL | 2025-12-09 | 2025-12-10 | $30.98 | $1.6M | +9.6% | +12.1% | +2.7% |
| AXGN | SELL | 2025-06-10 | 2025-06-11 | $10.72 | $577K | +0.8% | +18.1% | +63.1% |
| AXGN | SELL | 2025-05-22 | 2025-05-23 | $11.20 | $305K | -3.6% | -12.6% | +41.4% |
| AXGN | SELL | 2025-05-19 | 2025-05-23 | $11.63 | $29K | -3.6% | -12.6% | +41.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.